{"pageContent": "Context: Most newly diagnosed prostate cancers are clinically localized, and major treatment options include surgery, radiation, or conservative management. Although conservative management can be a reasonable choice, there is little contemporary prostate-specific antigen (PSA)-era data on outcomes with this approach.", "metaData": {"source": "Characteristics of cases with unknown stage prostate cancer in a population-based cancer registry\nhttps://pubmed.ncbi.nlm.nih.gov/24103424/"}}